In summary, CCL2 and CCL22 secretion in the prostate cancer tumor microenvironment may induce not only direct metastasis of prostate cancer cells, but also promote the activation of TAMs and Tregs, which facilitate a suitable environment for cancer progression. The gene discussed is CCL22; the disease is prostate carcinoma.